Jaap Rip
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
Papers in
-
- RNA Interference and Gene Delivery 13
- Biomaterials 13
- Nanoparticle-Based Drug Delivery 11
- Co-authors
- Pieter J. Gaillard (14 shared papers)John J.P. Kastelein (15 shared papers)Jan Albert Kuivenhoven (14 shared papers)Chantal C.M. Appeldoorn (7 shared papers)Arie Reijerkerk (4 shared papers)Colin J.D. Ross (8 shared papers)Michael R. Hayden (8 shared papers)Margareta Hammarlund‐Udenaes (4 shared papers)
- Journals
- Human Gene Therapy (6 papers)Arteriosclerosis Thrombosis and Vascular Biology (4 papers)Drug Discovery Today Technologies (3 papers)Journal of Controlled Release (3 papers)Molecular Pharmaceutics (2 papers)
- Partner nations
- NetherlandsCanadaSweden
In The Last Decade
Jaap Rip
40 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 90
- Biomaterials 406
- Pharmaceutical Science 182
- Neurology 112
- Cardiology and Cardiovascular Medicine 296
- Endocrinology, Diabetes and Metabolism 215
Countries citing papers authored by Jaap Rip
This map shows the geographic impact of Jaap Rip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaap Rip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaap Rip more than expected).
Fields of papers citing papers by Jaap Rip
This network shows the impact of papers produced by Jaap Rip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaap Rip. The network helps show where Jaap Rip may publish in the future.
Co-authors
The 25 scholars most cited alongside Jaap Rip, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 146 | |
| 2 | 2006 | 124 | |
| 3 | 2014 | 119 | |
| 4 | 2015 | 114 | |
| 5 | 2012 | 78 | |
| 6 | 2009 | 69 | |
| 7 | 2016 | 65 | |
| 8 | 2004 | 63 | |
| 9 | 2006 | 60 | |
| 10 | 2005 | 56 | |
| 11 | 2005 | 55 | |
| 12 | 2005 | 51 | |
| 13 | 2015 | 42 | |
| 14 | 2011 | 35 | |
| 15 | 2022 | 34 | |
| 16 | 2017 | 31 | |
| 17 | 2016 | 29 | |
| 18 | 2014 | 23 | |
| 19 | 2005 | 21 | |
| 20 | 2005 | 19 |
About Jaap Rip
Jaap Rip is a scholar working on Molecular Biology, Biomaterials, Cardiology and Cardiovascular Medicine, Genetics and Surgery, having authored 42 papers that have together received 1.4k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (13 papers), Nanoparticle-Based Drug Delivery (11 papers), Diabetes and associated disorders (10 papers), Lipid metabolism and disorders (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Virus-based gene therapy research (6 papers), Nanoplatforms for cancer theranostics (5 papers) and Barrier Structure and Function Studies (4 papers). The work is most often cited by research in Biomaterials (406 citations), Pharmaceutical Science (182 citations), Neurology (112 citations), Cardiology and Cardiovascular Medicine (296 citations) and Endocrinology, Diabetes and Metabolism (215 citations). Jaap Rip has collaborated with scholars based in Netherlands, Canada and Sweden. Frequent co-authors include Pieter J. Gaillard, John J.P. Kastelein, Jan Albert Kuivenhoven, Chantal C.M. Appeldoorn, Arie Reijerkerk, Colin J.D. Ross, Michael R. Hayden, Margareta Hammarlund‐Udenaes, Melchior C. Nierman and Erik S.G. Stroes. Their work appears in journals such as Human Gene Therapy, Arteriosclerosis Thrombosis and Vascular Biology, Drug Discovery Today Technologies, Journal of Controlled Release and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.